Alvotech (ALVO) Current Deferred Revenue (2020 - 2026)
Alvotech's (ALVO) quarterly Current Deferred Revenue came in at $4.2 million in Q2 2026, down 67.66% on a YoY basis from $12.9 million in Q2 2025, and down 68.18% quarter-over-quarter from $13.1 million in Q1 2026.
Analysis
Alvotech (ALVO) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Current Deferred Revenue for 7 consecutive years, with $4.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Deferred Revenue fell 67.66% year-over-year to $4.2 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (down 67.66% YoY), and the FY2025 full-year result was $5.5 million, down 93.19% from the prior year.
- Current Deferred Revenue declined to $4.2 million in Q2 2026 per ALVO's latest filing, from $13.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $90.1 million in Q2 2024 and bottomed at $4.2 million in Q2 2026.
- Historically, Current Deferred Revenue has averaged $54.3 million across 5 years, with a median of $65.3 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue surged 91.4% in 2023, then sank 93.19% in 2025.
- Over 5 years, Current Deferred Revenue stood at $57.0 million in 2022, then climbed by 28.49% to $73.3 million in 2023, then advanced by 10.18% to $80.7 million in 2024, then tumbled by 93.19% to $5.5 million in 2025, then retreated by 24.05% to $4.2 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.2 million, $13.1 million, and $5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.18 Mn |
| Mar 31, 2026 | 13.13 Mn |
| Dec 31, 2025 | 5.50 Mn |
| Sep 30, 2025 | 80.72 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | 80.72 Mn |
| Dec 31, 2024 | 80.72 Mn |
| Sep 30, 2024 | 85.50 Mn |
| Jun 30, 2024 | 90.12 Mn |
| Mar 31, 2024 | 88.91 Mn |
| Dec 31, 2023 | 73.26 Mn |
| Jun 30, 2023 | 57.39 Mn |
| Dec 31, 2022 | 57.02 Mn |
| Jun 30, 2022 | 29.98 Mn |
| Dec 31, 2021 | 44.84 Mn |
| Dec 31, 2020 | 38.87 Mn |